Covid-19 roundup: As­pen to pro­duce gener­ic J&J vac­cine for Africa; First boost­ers for un­der-18-year-olds could come next week — re­port

Af­ter some ups and downs sur­round­ing the man­u­fac­tur­ing of J&J’s Covid-19 vac­cine as the South African com­pa­ny’s site, As­pen Phar­ma­care has an­nounced an agree­ment with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER